TQ Quiz | Clinical Grand Rounds in Optic Neuropathies: “You’ve Got Some Nerve!” (Scottsdale 2025) by Events@optometricedu.com | Jan 27, 2025 | 2025 Scottsdale, TQ Courses | 0 comments "*" indicates required fields This field is hidden when viewing the formDate (Hidden) MM slash DD slash YYYY This field is hidden when viewing the formEvent Date (Hidden) MM slash DD slash YYYY This field is hidden when viewing the formEvent 60 days past date (Hidden) MM slash DD slash YYYY This field is hidden when viewing the formEvent Date Difference (Hidden)1. What term refers to edema of the optic disc, specifically resulting from elevated intracranial pressure?* A. Papilledema B. Optic atrophy C. Infectious optic neuropathy D. Optic disc drusen 2. In papilledema, what parts of the optic nerve are affected first?* A. Nasal and temporal B. Superior and temporal C. Superior and inferior D. Nasal and inferior 3. What is an early visual field defect in papilledema?* A. Nasal step B. Peripheral constriction C. Enlarged blind spot D. Arcuate defect 4. What is a late visual field defect in papilledema?* A. Nasal step B. Peripheral constriction and arcuate defect C. Enlarged blind spot D. Hemianopsia 5. Which of the following is not a typical symptom of papilledema?* A. Headache B. Transient visual obscurations C. Horizontal diplopia D. Eye pain 6. How many types of papilledema are recognized?* A. One B. Two C. Three D. Four 7. Which of the following is not a typical sign associated with papilledema?* A. Obliteration of optic cup B. Hemorrhages C. Presence of spontaneous venous pulsation (SVP) D. Paton’s folds 8. In diagnosing pseudotumor cerebri (PTC) in adults, what must the opening lumbar pressure be above?* A. 150 mm B. 180 mm C. 200 mm D. 250 mm 9. In diagnosing pseudotumor cerebri (PTC) in a non-obese, non-sedated child, what must the opening lumbar pressure be above?* A. 150 mm B. 280 mm C. 200 mm D. 250 mm 10. Which of the following medications is not used to manage pseudotumor cerebri?* A. Acetazolamide B. Furosemide C. Blephamide D. Zonisamide 11. What surgical procedure is recommended to reduce morbidity in patients with severe vision loss from pseudotumor cerebri?* A. Optic nerve sheath decompression B. Trabeculectomy C. Phacoemulsification D. Ahmed drainage implant 12. What condition presents with a hyperemic swollen disc and a disc at risk?* A. Papilledema B. Non-arteritic anterior ischemic neuropathy (NAAION) C. Arteritic anterior ischemic optic neuropathy (AAION) D. Infiltrative optic neuropathy 13. What symptom is present in 90% of patients with giant cell arteritis and arteritic anterior ischemic optic neuropathy?* A. Jaw claudication B. Weight loss C. Arthralgia D. Headache 14. Bilateral temporal disc pallor is most associated with what cause?* A. Brain tumor B. Orbital tumor C. Toxic/ nutritional issues D. Glaucoma 15. Neuroretinitis and positive testing for bartonella point to what disease?* A. Cat scratch disease B. Syphilis C. Toxoplasmosis D. AIDS 16. Which of the following is a steroid-sparing medication used in treating giant cell arteritis and arteritic anterior ischemic optic neuropathy?* A. Tapezza (teprotumumab) B. Actemra (tocilizumab) C. Humira (adalimumab) D. Ozempic (semaglutide) 17. Trauma and compression (e.g. tumor) cause what type of optic atrophy?* A. Primary B. Secondary C. Tertiary D. Consecutive 18. What is the most common cause of compressive optic neuropathy?* A. Pituitary adenoma B. Craniopharyngioma C. Optic nerve sheath meningioma D. Infiltrated extraocular muscles (Graves’ ophthalmopathy) in thyroid disease 19. For patient with optic neuritis in the Optic Neuritis Treatment Trial (ONTT), of those that had a normal MRI at baseline and no clinical definite multiple sclerosis (CDMS) at 10 years, what would the risk be of developing multiple sclerosis at 15 years?* A. 2% B. 17% C. 32% D. 57% 20. What condition involves optic neuritis and transverse myelitis?* A. Multiple sclerosis B. Myelin oligodendrocyte glycoprotein antibody associated disease (MOGAD) C. Neuromyelitis Optica Syndrome Disorder (NMOSD) D. Infectious optic neuropathy Personal InformationName* First Last Email* Phone*OE Tracker #License #Address* Street Address Address Line 2 City State / Province / Region ZIP / Postal Code AfghanistanAlbaniaAlgeriaAmerican SamoaAndorraAngolaAnguillaAntarcticaAntigua and BarbudaArgentinaArmeniaArubaAustraliaAustriaAzerbaijanBahamasBahrainBangladeshBarbadosBelarusBelgiumBelizeBeninBermudaBhutanBoliviaBonaire, Sint Eustatius and SabaBosnia and HerzegovinaBotswanaBouvet IslandBrazilBritish Indian Ocean TerritoryBrunei DarussalamBulgariaBurkina FasoBurundiCabo VerdeCambodiaCameroonCanadaCayman IslandsCentral African RepublicChadChileChinaChristmas IslandCocos IslandsColombiaComorosCongoCongo, Democratic Republic of theCook IslandsCosta RicaCroatiaCubaCuraçaoCyprusCzechiaCôte d'IvoireDenmarkDjiboutiDominicaDominican RepublicEcuadorEgyptEl SalvadorEquatorial GuineaEritreaEstoniaEswatiniEthiopiaFalkland IslandsFaroe IslandsFijiFinlandFranceFrench GuianaFrench PolynesiaFrench Southern TerritoriesGabonGambiaGeorgiaGermanyGhanaGibraltarGreeceGreenlandGrenadaGuadeloupeGuamGuatemalaGuernseyGuineaGuinea-BissauGuyanaHaitiHeard Island and McDonald IslandsHoly SeeHondurasHong KongHungaryIcelandIndiaIndonesiaIranIraqIrelandIsle of ManIsraelItalyJamaicaJapanJerseyJordanKazakhstanKenyaKiribatiKorea, Democratic People's Republic ofKorea, Republic ofKuwaitKyrgyzstanLao People's Democratic RepublicLatviaLebanonLesothoLiberiaLibyaLiechtensteinLithuaniaLuxembourgMacaoMadagascarMalawiMalaysiaMaldivesMaliMaltaMarshall IslandsMartiniqueMauritaniaMauritiusMayotteMexicoMicronesiaMoldovaMonacoMongoliaMontenegroMontserratMoroccoMozambiqueMyanmarNamibiaNauruNepalNetherlandsNew CaledoniaNew ZealandNicaraguaNigerNigeriaNiueNorfolk IslandNorth MacedoniaNorthern Mariana IslandsNorwayOmanPakistanPalauPalestine, State ofPanamaPapua New GuineaParaguayPeruPhilippinesPitcairnPolandPortugalPuerto RicoQatarRomaniaRussian FederationRwandaRéunionSaint BarthélemySaint Helena, Ascension and Tristan da CunhaSaint Kitts and NevisSaint LuciaSaint MartinSaint Pierre and MiquelonSaint Vincent and the GrenadinesSamoaSan MarinoSao Tome and PrincipeSaudi ArabiaSenegalSerbiaSeychellesSierra LeoneSingaporeSint MaartenSlovakiaSloveniaSolomon IslandsSomaliaSouth AfricaSouth Georgia and the South Sandwich IslandsSouth SudanSpainSri LankaSudanSurinameSvalbard and Jan MayenSwedenSwitzerlandSyria Arab RepublicTaiwanTajikistanTanzania, the United Republic ofThailandTimor-LesteTogoTokelauTongaTrinidad and TobagoTunisiaTurkmenistanTurks and Caicos IslandsTuvaluTürkiyeUS Minor Outlying IslandsUgandaUkraineUnited Arab EmiratesUnited KingdomUnited StatesUruguayUzbekistanVanuatuVenezuelaViet NamVirgin Islands, BritishVirgin Islands, U.S.Wallis and FutunaWestern SaharaYemenZambiaZimbabweÅland Islands Country Payment InformationPromotional CodeScottsdale 2025 - Clinical Grand Rounds in Optic Neuropathies: “You’ve Got Some Nerve!”*After 90 days, pricing will increase to $30. Price: (Past 90 Days) Scottsdale 2025 - Clinical Grand Rounds in Optic Neuropathies: “You’ve Got Some Nerve!”This course was presented over 90 days ago. Due to this late submission of TQ, your TQ credit price is $30. Price: Retake Discount Price: Promotional Discount Price: (Past 60 Days) Retake Discount Price: (Past 60 Days) Promotional Discount Price: Credit Card* This field is hidden when viewing the formCourse Information (HIDDEN)This field is hidden when viewing the formCourse Name (HIDDEN)This field is hidden when viewing the formRetake Code (HIDDEN)This field is hidden when viewing the formQuiz URL (HIDDEN)Do not include ending backslash (aka no .com/)This field is hidden when viewing the formCE Hours Submit a Comment Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website
